These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 1438305)
21. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice. Gyotoku E; Morita E; Kameyoshi Y; Hiragun T; Yamamoto S; Hide M Arch Dermatol Res; 2001 Nov; 293(10):508-14. PubMed ID: 11820727 [TBL] [Abstract][Full Text] [Related]
22. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family. Wegenka UM; Lütticken C; Buschmann J; Yuan J; Lottspeich F; Müller-Esterl W; Schindler C; Roeb E; Heinrich PC; Horn F Mol Cell Biol; 1994 May; 14(5):3186-96. PubMed ID: 8164674 [TBL] [Abstract][Full Text] [Related]
23. Gp130 in human myeloma/plasmacytoma. Tani Y; Nishimoto N; Ogata A; Shima Y; Yoshizaki K; Kishimoto T Curr Top Microbiol Immunol; 1995; 194():229-33. PubMed ID: 7895494 [No Abstract] [Full Text] [Related]
24. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046 [TBL] [Abstract][Full Text] [Related]
25. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies. Murakami-Mori K; Taga T; Kishimoto T; Nakamura S J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807 [TBL] [Abstract][Full Text] [Related]
26. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Rowan AD; Koshy PJ; Shingleton WD; Degnan BA; Heath JK; Vernallis AB; Spaull JR; Life PF; Hudson K; Cawston TE Arthritis Rheum; 2001 Jul; 44(7):1620-32. PubMed ID: 11465713 [TBL] [Abstract][Full Text] [Related]
27. Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production. Terada S; Suzuki E; Ueda H; Makishima F Cytokine; 1996 Dec; 8(12):889-94. PubMed ID: 9050746 [TBL] [Abstract][Full Text] [Related]
28. LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit. Modrell B; Liu J; Miller H; Shoyab M Growth Factors; 1994; 11(2):81-91. PubMed ID: 7857660 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. Liu J; Modrell B; Aruffo A; Marken JS; Taga T; Yasukawa K; Murakami M; Kishimoto T; Shoyab M J Biol Chem; 1992 Aug; 267(24):16763-6. PubMed ID: 1324910 [TBL] [Abstract][Full Text] [Related]
30. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Stahl N; Boulton TG; Farruggella T; Ip NY; Davis S; Witthuhn BA; Quelle FW; Silvennoinen O; Barbieri G; Pellegrini S Science; 1994 Jan; 263(5143):92-5. PubMed ID: 8272873 [TBL] [Abstract][Full Text] [Related]
31. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain. Watanabe D; Yoshimura R; Khalil M; Yoshida K; Kishimoto T; Taga T; Kiyama H Eur J Neurosci; 1996 Aug; 8(8):1630-40. PubMed ID: 8921254 [TBL] [Abstract][Full Text] [Related]
32. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response. Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548 [TBL] [Abstract][Full Text] [Related]
33. Cytokines that use gp130 as a signal transducer stimulate mouse placental lactogen-I (mPL-I) but inhibit mPL-II production in vitro. Yamaguchi M; Taga T; Kishimoto T; Miyake A Biol Reprod; 1995 Aug; 53(2):399-406. PubMed ID: 7492693 [TBL] [Abstract][Full Text] [Related]
34. Interactions between oncostatin M and the IL-6 signal transducer, gp130. Liu J; Modrell B; Aruffo A; Scharnowske S; Shoyab M Cytokine; 1994 May; 6(3):272-8. PubMed ID: 8054483 [TBL] [Abstract][Full Text] [Related]
35. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex. Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501 [TBL] [Abstract][Full Text] [Related]
36. Identification of a 130-kilodalton tyrosine-phosphorylated protein induced by interleukin-11 as JAK2 tyrosine kinase, which associates with gp130 signal transducer. Yin T; Yasukawa K; Taga T; Kishimoto T; Yang YC Exp Hematol; 1994 May; 22(5):467-72. PubMed ID: 8174677 [TBL] [Abstract][Full Text] [Related]
37. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Minami M; Inoue M; Wei S; Takeda K; Matsumoto M; Kishimoto T; Akira S Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3963-6. PubMed ID: 8632998 [TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040 [TBL] [Abstract][Full Text] [Related]
39. Induction of an interferon-gamma Stat3 response in nerve cells by pre-treatment with gp130 cytokines. Kaur N; Kim IJ; Higgins D; Halvorsen SW J Neurochem; 2003 Oct; 87(2):437-47. PubMed ID: 14511121 [TBL] [Abstract][Full Text] [Related]
40. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Gearing DP; Comeau MR; Friend DJ; Gimpel SD; Thut CJ; McGourty J; Brasher KK; King JA; Gillis S; Mosley B Science; 1992 Mar; 255(5050):1434-7. PubMed ID: 1542794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]